trans-4-Dimethylaminocrotonic Acid Hydrochloride CAS 848133-35-7 Maʻemaʻe >98.0% (HPLC) Afatinib Dimaleate Intermediate
ʻO Ruifu Nā Kūwaena Hoʻolako Kimia o Afatinib
Afatinib CAS 439081-18-2
Afatinib Dimaleate CAS 850140-73-7
(S)-(+)-3-Hydroxytetrahydrofuran CAS 86087-23-2
(Dimethylamino)acetaldehyde Diethyl Acetal CAS 3616-56-6
trans-4-Dimethylaminocrotonic Acid Hydrochloride CAS 848133-35-7
Diethylphosphonoacetic Acid CAS 3095-95-2
7-Fluoro-6-Nitroquinazolin-4(1H)-hoʻokahi CAS 162012-69-3
7-Chloro-6-Nitro-4-Hydroxyquinazoline CAS 53449-14-2
N-(3-Chloro-4-Fluorophenyl)-7-Fluoro-6-Nitroquinazolin-4-Amine CAS 162012-67-1
(S)-N4-(3-Chloro-4-Fluorophenyl)-7-((Tetrahydrofuran-3-yl)oxy)quinazoline-4,6-DiamineCAS 314771-76-1
(S)-N-(3-Chloro-4-Fluorophenyl)-6-Nitro-7-((Tetrahydrofuran-3-yl) oxy)quinazolin-4-AmineCAS 314771-88-5
Inoa Kimia | trans-4-Dimethylaminocrotonic Acid Hydrochloride |
Nā huaʻōlelo like | trans 4-Dimethylaminocrotonic Acid HCl;(E)-4-(Dimethylamino)-2-Butenoic Acid Hydrochloride;(E)-4-Dimethylaminocrotonic Acid Hydrochloride;(2E) -4- (Dimethylamino) aka-2-Enoic Acid Hydrochloride;Afatinib int-2 |
Helu CAS | 848133-35-7 |
Kūlana Kūʻai | Ma ka Waihona, Ka Uuna Kūʻai |
ʻĀpana Molekala | C6H12ClNO2 |
Kaumaha Molecular | 165.62 |
ʻO ka ʻike | Hygroscopic.ʻAiʻoniʻoni |
Lae hehee | 160.0 a 164.0 ℃ |
Ka hikiwawe | DMSO (Lihi), Methanol (Lihi), Wai (Lihi) |
COA & MSDS | Loaʻa |
Ke kumu | Shanghai, Kina |
Brand | Kemika Ruifu |
'ikamu | Nā kikoʻī |
Ka nana aku | Keokeo a aneane keokeo pauda |
Maʻemaʻe / Kaʻina Hanana | >98.0% (HPLC) |
Maʻemaʻe / Kaʻina Hanana | >98.0% (NMR) |
Māmā (KF) | <0.50% |
Koena ma ka Ignition | <0.20% |
Hoʻokahi haumia | <0.50% |
Nā Metala Kaumaha (e like me Pb) | <20ppm |
Infrared Spectrum | Kūlike i ka hoʻolālā |
1 H NMR Spectrum | Proton NMR Spectrum |
Kūlana hoʻāʻo | Kūlana ʻoihana |
Hoʻohana | Ka waena o Afatinib, Afatinib Dimaleate |
Pūʻolo:ʻO ka ʻōmole, ʻeke ʻeke alumini, 25kg / pahu pahu pahu, a i ʻole e like me ka makemake o ka mea kūʻai aku.
Kūlana mālama:E mālama i loko o nā pahu i hoʻopaʻa ʻia ma kahi maloʻo a maloʻo;E pale i ka malamalama a me ka wai.
Hoʻouna:Hāʻawi i ka honua ma ka lewa, e FedEx / DHL Express.Hāʻawi wikiwiki a hilinaʻi hoʻi.
Mea hana: Agilent 1200 HPLC HPLC chromatograph, DAD detector.
Kona: Agilent XDB-C18,250*4.6mm, 5μm
Māhele Mobile: B: 1.95g sodium octane sulfonate + 8ml phosphoric acid + 5ml triethylamine + 500ml wai
C: acetonitrile
Ka hoʻomākaukau ʻana i ka māhele kelepona hui ʻia: e lawe i ka solution 400ml B a me 100ml acetonitrile, hui maikaʻi a like, a paʻi i ka wai i hoʻokahi pae.
Kahe kahe: 0.5ml/min54bar
Ka wela o ke kolamu: 25 ℃
Loʻihi nalu: 210nm
Laʻana hoʻonā: ua hoʻohana ʻia ka pae kelepona e like me ka solvent, ka laʻana paʻa: 0.0040g/2ml, ka nui o ka laʻana 2.0μl.
ʻO ka trans-4-Dimethylaminocrotonic Acid Hydrochloride (CAS: 848133-35-7) kahi reagent i hoʻohana ʻia i ka hoʻomākaukau ʻana i ka tyrosine kinase e kāohi ana i nā mea antitumor.Hiki ke hoʻohana ʻia ka trans-4-Dimethylaminocrotonic Acid Hydrochloride ma ke ʻano he waena o Afatinib (CAS: 439081-18-2), Afatinib Dimaleate (CAS: 850140-73-7), Neratinib (CAS: 698387-09-6).He lāʻau lapaʻau ʻo Afatinib i ʻae ʻia no ka mālama ʻana i ka maʻi maʻi maʻi maʻi ʻole liʻiliʻi liʻiliʻi (NSCLC), i hoʻomohala ʻia e Boehringer Ingelheim.Hana ia ma ke ʻano he angiokinase inhibitor.E like me Lapatinib a me Neratinib, ʻo Afatinib he tyrosine kinase inhibitor (TKI) e pale ʻole i ka epidermal growth factor receptor 2 (Her2) a me ka epidermal growth factor receptor (EGFR) kinases.ʻAʻole ikaika wale ʻo Afatinib i ka EGFRnā hoʻololi i manaʻo ʻia e nā TKI o ka hanauna mua likeerlotinib a i ʻole gefitinib, akā kūʻē pū kekahi i ka poʻe ʻike ʻole i kēia mau lāʻau lapaʻau maʻamau.Ma muli o kāna hana hou aku e kūʻē iā Her2, ke noiʻi ʻia nei no ka maʻi maʻi umauma a me nā maʻi maʻi maʻi EGFR a me Her2 ʻē aʻe.ʻO Neratinib i hoʻomohala ʻia e ka hui ʻo US Wyeth he mea hiki ʻole ke hoʻololi i ka epidermal growth factor receptor (EGFR) inhibitor.He wahi pahuhopu nui ia o nā mole liʻiliʻi tyrosine kinase inhibitors i HER 2 a me HER1 ma hope o Lapatinib, a he mea hiki ole ke hoʻololi i ka ErbB receptor tyrosine kinase inhibitor.Hiki i ka Neratinib ke kaohi i ka HER-1 a me HER-2 o ka ʻohana EGFR (ʻo IC50 he 92 nmol/L a me 59 nmol/L, kēlā me kēia).Ua hōʻike ʻia ka noiʻi haukaʻi ua hoʻohana ʻo Neratinib i ka hopena therapeutic koʻikoʻi ma luna o ka maʻi maʻi ʻaʻai liʻiliʻi liʻiliʻi, ka maʻi ʻaʻai colon, a me ka maʻi maʻi umauma.Ua hōʻike ka phaseⅡclinical trial ua hōʻike ʻo Neratinib i ka maikaʻi a me ka hoʻomanawanui ʻana i nā maʻi maʻi HER-2 maikaʻi me ka maʻi maʻi umauma kiʻekiʻe i loaʻa a ʻaʻole i mālama ʻia ʻo Trastuzumab.Ua hoʻopau ʻia ka pae Ⅲ ka hoʻāʻo ʻana i ka maʻi maʻi umauma ma Kepakemapa 2014.